Hanmi Science Company is Drug Discovery in South Korea that focus on Science Co Ltd business. Founded in 1973. They cover business area such as Hanmi Science Co Ltd, its subsidiary, pharmaceutical product, prescription drug, neuropathic pain, obesity, epilepsy, intestinal supplement, oral care, hair growth, inflammatory, schizophrenia, smoking cessation aid, diabetes, osteoporosis, antiemetic, vaginal contraceptive, expectorant.
1973
( 51 years old in 2024 )
Science Co Ltd
-
214 Muha-ro Paltan-myeon
Gyeonggi-do
Hwaseong
South Korea
Private
Hanmi Science Co Ltdits subsidiarypharmaceutical productprescription drugneuropathic painobesityepilepsyintestinal supplementoral carehair growthinflammatory, schizophrenia, smoking cessation aiddiabetesosteoporosisantiemeticvaginal contraceptiveexpectorant
* We use standard office opening hours in near Hanmi Science Company's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Hanmi Science Company is Drug Discovery business from South Korea that founded in 1973 (51 years old in 2024), Hanmi Science Company business is focusing on Science Co Ltd.
Hanmi Science Company headquarter office and corporate office address is located in 214 Muha-ro Paltan-myeon Gyeonggi-do Hwaseong South Korea.
Hanmi Science Company was founded in South Korea.
In 2024, Hanmi Science Company is currently focus on Science Co Ltd sector.
Above is snippet of Google Trends for "Science Co Ltd" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Hanmi Science Company, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
